Comparing the pharmacological effects of the novel Locked Nucleic Acid (LNA) modified antisense Bcl-2 inhibitor SPC2996 and G3139 (oblimersen) in preclinical models of chronic lymphocytic leukemia: V613
- Resource Type
- Academic Journal
- Source
- Onkologie. Oct 01, 2010 33 Suppl. 6:184-184
- Subject
- Language
- English
- ISSN
- 0378-584X